Blandini F - Search Results

1

Are Lysosomes Potential Therapeutic Targets for Parkinson's Disease?

Petese A, Cesaroni V, Cerri S, Blandini F. Petese A, et al. Among authors: blandini f. CNS Neurol Disord Drug Targets. 2022;21(8):642-655. doi: 10.2174/1871527320666210809123630. CNS Neurol Disord Drug Targets. 2022. PMID: 34370650 Review.

2

Glutamate and Parkinson's disease.

Blandini F, Porter RH, Greenamyre JT. Blandini F, et al. Mol Neurobiol. 1996 Feb;12(1):73-94. doi: 10.1007/BF02740748. Mol Neurobiol. 1996. PMID: 8732541 Review.

3

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

Blandini F. Blandini F. CNS Drug Rev. 2005 Summer;11(2):183-94. doi: 10.1111/j.1527-3458.2005.tb00269.x. CNS Drug Rev. 2005. PMID: 16007239 Free PMC article. Review.

4

Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.

Armentero MT, Levandis G, Bazzini E, Cerri S, Ghezzi C, Blandini F. Armentero MT, et al. Among authors: blandini f. Neurobiol Dis. 2011 Sep;43(3):663-8. doi: 10.1016/j.nbd.2011.05.017. Epub 2011 Jun 12. Neurobiol Dis. 2011. PMID: 21684338

5

Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease.

Cova L, Bossolasco P, Armentero MT, Diana V, Zennaro E, Mellone M, Calzarossa C, Cerri S, Deliliers GL, Polli E, Blandini F, Silani V. Cova L, et al. Among authors: blandini f. Apoptosis. 2012 Mar;17(3):289-304. doi: 10.1007/s10495-011-0679-9. Apoptosis. 2012. PMID: 22160861

6

Animal models of Parkinson's disease.

Blandini F, Armentero MT. Blandini F, et al. FEBS J. 2012 Apr;279(7):1156-66. doi: 10.1111/j.1742-4658.2012.08491.x. Epub 2012 Feb 28. FEBS J. 2012. PMID: 22251459 Free article. Review.

7

Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease.

Bossolasco P, Cova L, Levandis G, Diana V, Cerri S, Lambertenghi Deliliers G, Polli E, Silani V, Blandini F, Armentero MT. Bossolasco P, et al. Among authors: blandini f. Int J Nanomedicine. 2012;7:435-47. doi: 10.2147/IJN.S27537. Epub 2012 Jan 31. Int J Nanomedicine. 2012. PMID: 22334776 Free PMC article.

8

Neural and immune mechanisms in the pathogenesis of Parkinson's disease.

Blandini F. Blandini F. J Neuroimmune Pharmacol. 2013 Mar;8(1):189-201. doi: 10.1007/s11481-013-9435-y. Epub 2013 Feb 3. J Neuroimmune Pharmacol. 2013. PMID: 23378275 Review.

9

Dopamine receptor agonists for Parkinson's disease.

Blandini F, Armentero MT. Blandini F, et al. Expert Opin Investig Drugs. 2014 Mar;23(3):387-410. doi: 10.1517/13543784.2014.869209. Epub 2013 Dec 9. Expert Opin Investig Drugs. 2014. PMID: 24313341 Review.

10

A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease.

Ambrosi G, Cerri S, Blandini F. Ambrosi G, et al. Among authors: blandini f. J Neural Transm (Vienna). 2014 Aug;121(8):849-59. doi: 10.1007/s00702-013-1149-z. Epub 2014 Jan 1. J Neural Transm (Vienna). 2014. PMID: 24380931 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page